Bluesight’s Second Annual Medication Intelligence Summit
Transforming the hospital supply chain
through medication intelligence.
Panels on Latest Pharmacy Trends
Hear from your peers and representatives from other organizations throughout the supply chain on the latest drug diversion management, inventory management, and drug purchasing trends. Each panel is led by one of Bluesight’s clinical staff members. Topics from Bluesight’s latest research white papers will be brought to the forefront of each panel.
You can earn pharmacist continuing education credits right before ASHP in Phoenix. You won’t want to miss the session on Tuesday “The State of 340B”! You’ll leave with skills that can be immediately applied into your day to day routine.
Explore Innovative Solutions
Bluesight will be announcing new product features during the Summit. Each focused on bringing simplicity, visibility and predictability to a complex world of care. These sessions will provide you a more in depth look at some of the new advancements in the hospital pharmacy space.
Day 1- Medication Management
11:00 PM → 3:00 PM EST
The first day of the summit is focused on Medication Management. The day is started with a panel of experts discussing some trends in the industry around RFID. This will be followed by sessions focused on workflow optimizations, findings from Bluesight’s lastest Hopsital Pharmacy Operations Report and a panel on the current challenges in medication management.
Day 2- Purchasing and Supply Chain
12:00 PM → 4:00 PM EST
Day 2 kicks off with an interview with CostCheck’s Product Owner about how his team works to fix pharamcy purchasing problems with the solution. This is followed up by an indepth discussion of Pharmacy Purchasing at the IDN level and a new methodolgy for scoring the quality of Drugs. Near the end of the day we will be looking at future trends specifically focused on E-Commerce and the 340B program.
Day 3- Diversion Monitoring
12:00 PM → 4:00 PM EST
Day 3 starts off with an interview panel around the importance of education when it comes to drug diversion prevention. This is followed up by a State of Drug Diversion based off the results of Bluesight’s latest Hospital Pharmacy Operations Report. The rest of the day consists of conversations with diversion specialists, nurses and pharmacists around diversion investigations and best practices.
Fred Pane is Director Pharmacy Services, Capstone Health Alliance, where he is developing new contracting models and working with Capstone Health Alliance members to address todays evolving healthcare ecosystem and challenges, while delivering clinical and financial value to Capstone members and their patients. Fred has a diverse background including creating an Enterprise Pharmacy Operations at an IDN in Pennsylvania, which was recognized as a Most Wired Hospital, as the Administrator of Pharmacy Services, while implementing robotics, BCMA, CPOE in the mid/late 1990’s. He coordinated Pharmacy Formulary and Protocol Development for an 11 Hospital IDN/ACO, with 3000 beds, called PennCARE with 100K at risk lives and Chaired P and T Committee for the Health-system, building an evidence-based formulary tied into quality metrics and measuring 30-day readmissions.
His experience includes, Sr. VP Business Development, Comprehensive Pharmacy Services; VP, Pharmacy Services and VP, Supply Chain for Coordinated Health, Allentown, Pa; PhRMA industry as Sr. Director, National Accounts/Health Care Systems/Pharmacy Solutions, The Medicines Company. Prior to The Medicines Company, Sr. Director, Pharmacy Affairs at the GPO, Premier Inc.
Fred received his BS Pharmacy from St. John’s University, School of Pharmacy, attended Leadership Programs in Pharmacy and Health Care, Univ. of Pa. Wharton School, and Thunderbird/Mid-Western University. He is a Fellow of The American Society of Health-system Pharmacy (FASHP) and completed an 18-month Fellowship, Healthcare Leadership, with The Advisory Board Company (FABC) with a focus on understanding the current and future healthcare ecosystem, along with leadership.
He provides input to American Society of Health-systems Pharmacy (ASHP) addressing issues that are impacting the profession of Health System Pharmacy, the Healthcare Ecosystem, and with The Advisory Board Company on Healthcare, Industry, Supply Chain, and Pharmacy issues. He has presented at numerous professional meetings and has numerous publications including, the first article on “White Bagging” and “Value Based Contracting”. He recently worked with several physicians, developing new Healthcare Economic Models for Devices, Drugs, and Diagnostics, providing input on creating a Clinically Integrated Supply Chain.
Arash Dabestani is currently the Dean and Professor at Long Island University College of Pharmacy. He was the Senior Director of Pharmacy at NYU Langone Health for eight years prior to joining academia, and previously served as associate director of pharmacy at Stanford University Hospital and Clinics. Prior to becoming a pharmacy administrator, he maintained an active clinical practice in hospital pharmacy and specialty pediatric home health care. Arash received his PharmD from Campbell University and his Master in Health Administration from the University of North Carolina (Charlotte). Arash has over 25 years of experience as a health system pharmacy executive (Sentara, NYU, and Stanford University), as well as a practicing pharmacist in community, hospital, home infusion, and specialty pharmacy.
He is considered a global subject matter expert in pharmacy technology, inventory automation, supply-chain, medication safety, and quality control. In 2007, Arash became a Senior Leadership Fellow of the Advisory Board in Washington DC after completing a two-year fellowship for high-performing emerging executives. That year, he also was named Virginia Society of Health-System Pharmacists pharmacist of the year. Arash has formed and facilitated multiple pharmacy leadership forums in Washington DC, New York, and the San Francisco Bay area. In 2023, he was invited to the White House to discuss the topic of medication quality. He currently lectures at NYU School of Dentistry and has previously lectured at the UCSF, Virginia Commonwealth, and Long Island University Schools of Pharmacy. Arash has served multiple terms on the ASHP Section of Pharmacy Practice Manager’s Leadership Development Section and was named a Fellow of ASHP in 2011.
Kenny is the Senior Director of Pharmacy Services at NYU Langone Hospitals system. He provides executive leadership and coordination for all pharmacy services provided within NYU Langone Hospitals to promote standardization and alignment of practices across all pharmacy sites.
He has helped to coordinate pharmacy initiatives across the enterprise, including working closely with the pharmacy leaders at our five hospital locations, investigational pharmacy, hospital-owned retail pharmacy, hospital-owned specialty pharmacy, standalone ED pharmacy, and multiple infusion center pharmacies. Administratively, he has oversight over 20 pharmacies in the system, pharmacy strategy, and business, the 340B Program, medication safety and quality, regulatory and compliance, clinical services, and pharmacy systems.
Prior to his current role, Kenny served as the inaugural Director of 340B Program starting in 2016. He managed both compliance and optimization of the 340B Program, where he and his team built the program from the ground. His role evolved into a dual focus in 2018, engaging in Pharmacy Business and Analytics, as well, where he has supported pharmacy-related contract negotiations, pharmacy projects/initiatives, and pharmacy-driven analyses.
Prior to assuming his 340B Director’s role, Kenny served as the Assistant Director of Pharmacy, Ambulatory Services, where he had a dual role of managing an infusion center pharmacy and handling all medication management for NYU Langone Hospitals in the ambulatory care setting to promote safety and standardization. Before he stepped into pharmacy leadership, Kenny was an oncology pharmacist at the Perlmutter Cancer Center.
Kenny received his doctorate of pharmacy from Rutgers University in New Jersey and his master’s in business administration with a concentration in healthcare from George Washington University in Washington, DC. He became a 340B Apexus Certified Expert (ACE) in 2017.